In recent months, Parnassus Core Equity Fund disclosed a new position in Boston Scientific, while TD Cowen reiterated its positive stance and named the medical device maker its “Best Idea for 2026,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback